quinolinic acid and roflumilast

quinolinic acid has been researched along with roflumilast in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bhat, A; Chidambaram, SB; Essa, MM; Guillemin, GJ; Heng, B; Lovejoy, DB; Sakharkar, MK; Tan, V1
Akhtar, A; Bansal, Y; Bishnoi, M; Kuhad, A; Sah, SP; Saroj, P; Singh, R; Sodhi, RK1

Other Studies

2 other study(ies) available for quinolinic acid and roflumilast

ArticleYear
Roflumilast, a cAMP-Specific Phosphodiesterase-4 Inhibitor, Reduces Oxidative Stress and Improves Synapse Functions in Human Cortical Neurons Exposed to the Excitotoxin Quinolinic Acid.
    ACS chemical neuroscience, 2020, 12-16, Volume: 11, Issue:24

    Topics: Aminopyridines; Benzamides; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Humans; Neurons; Neurotoxins; Oxidative Stress; Phosphodiesterase 4 Inhibitors; Quinolinic Acid; Synapses

2020
Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington's disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway.
    Inflammopharmacology, 2021, Volume: 29, Issue:2

    Topics: Aminopyridines; Animals; Benzamides; Brain-Derived Neurotrophic Factor; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Huntington Disease; Inflammation; Male; Neuroprotective Agents; NF-kappa B; Nitrosative Stress; Oxidative Stress; Quinolinic Acid; Rats; Rats, Wistar; Signal Transduction

2021